Form 4: Envista Exec Befidi Boosts Holdings with Equity Grants

Envista Holdings Corp's President of Diagnostics, Robert Befidi, reported significant equity grants including Restricted Stock Units, Performance Share Units, and stock options.

Summary

• Robert Befidi, President of Diagnostics at Envista Holdings Corp (NVST), reported transactions on February 25, 2026.
• Disposed of 2,177 shares of common stock at $29.59 to satisfy tax withholding obligations applicable to the vesting of Restricted Stock Units (RSUs).
• Acquired 7,605 shares of common stock from the vesting of RSUs, which will vest ratably on each anniversary of the grant date over three years, subject to continued service.
• Acquired 13,845 Performance Share Units (PSUs) at target performance, which will vest based on the achievement of identified performance measures over a three-year performance period (0%-200% payout possible).
• Acquired 18,020 Employee Stock Options with an exercise price of $29.59, which will vest ratably on each anniversary of the grant date over three years, subject to continued service, and expire on February 25, 2036.
• Following these transactions, Befidi beneficially owns 50,932 shares of common stock, 13,845 Performance Share Units, and 18,020 Employee Stock Options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development as it reflects standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational or financial concerns.

Positives

• Significant equity grants (7,605 RSUs, 13,845 PSUs, 18,020 stock options) align management's interests with long-term shareholder value.
• The acquisition of Performance Share Units (PSUs) ties a portion of compensation directly to the achievement of identified company performance measures.
• The stock options have a 10-year expiration, providing a long-term incentive for value creation.

Negatives

• The disposition of 2,177 shares was solely for tax withholding purposes, not a discretionary sale.

Future Outlook

The vesting schedules for RSUs, PSUs, and stock options extend over three years, indicating a long-term incentive structure for the reporting person, subject to continued service and performance targets for PSUs.

Industry Context

StockSavvy.ai notes that equity grants, particularly those tied to performance (PSUs) and long-term options, are standard practices in executive compensation across the medical technology and dental industries. These structures aim to incentivize executives to drive long-term growth and align their financial interests with those of shareholders.

Related Party Transactions

• The reported transactions are equity compensation grants to an executive officer, which are considered related party transactions in the context of executive compensation.

Stakeholder Impact

• Shareholders: The grants align executive incentives with shareholder interests, potentially leading to long-term value creation if performance targets are met.
• Employees: No direct impact on general employees is indicated, but it reflects the company's executive compensation strategy.

Next Steps

• Continued service by Robert Befidi through the vesting dates for RSUs and stock options.
• Achievement of identified performance measures over the three-year performance period for PSUs to determine the final number of shares earned.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation grants and tax-related dispositions, which are standard for publicly traded companies. It does not provide new information that would fundamentally alter the investment thesis for Envista Holdings Corp, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Envista Holdings Corp, NVST, Robert Befidi, Form 4, Insider Trading, Equity Grant, Restricted Stock Units, Performance Share Units, Stock Options, Executive Compensation, Corporate Governance